Literature DB >> 17295234

CpG site hypermethylation of E-cadherin and Connexin26 genes in hepatocellular carcinomas induced by a choline-deficient L-Amino Acid-defined diet in rats.

Toshifumi Tsujiuchi1, Kyoko Shimizu, Yumi Itsuzaki, Mariko Onishi, Eriko Sugata, Hiromasa Fujii, Kanya Honoki.   

Abstract

We investigated DNA methylation patterns of E-cadherin and Connexin26 (Cx26) genes in rat hepatocellular carcinomas (HCCs) induced by a choline-deficient L-Amino Acid-defined (CDAA) diet. Six-wks-old F344 male rats were continuously fed with a CDAA diet for 75 wks, and were then killed. A total of five HCCs were obtained, and genomic DNA was extracted from each HCC for assessment of methylation status in the 5' upstream regions of E-cadherin and Cx26 genes by bisulfite sequencing, comparing to two normal liver tissues. The five HCCs showed highly methylated E-cadherin and Cx26 genes, while these genes in two normal liver tissues were all unmethylated. For analysis of gene expression, real-time quantitative reverse transcription (RT)-polymerase chain reaction (PCR) was performed. Expressions of E-cadherin and Cx26 genes were significantly reduced in the five HCCs (P < 0.0001 and P < 0.001, respectively) compared to normal liver tissues, correlating with their methylation statuses. These results suggested that hypermethylation of E-cadherin and Cx26 genes may be involved in the development of HCCs induced by a CDAA diet in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295234     DOI: 10.1002/mc.20268

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  13 in total

Review 1.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 2.  Choline nutrition programs brain development via DNA and histone methylation.

Authors:  Jan Krzysztof Blusztajn; Tiffany J Mellott
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-06

Review 3.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

Review 4.  Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents.

Authors:  Igor P Pogribny; Ivan Rusyn; Frederick A Beland
Journal:  Environ Mol Mutagen       Date:  2008-01       Impact factor: 3.216

Review 5.  Current trends in the development and application of molecular technologies for cancer epigenetics.

Authors:  Hyeran Jang; Hyunjin Shin
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

Review 6.  Connexin and pannexin signaling in gastrointestinal and liver disease.

Authors:  Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Bruno Cogliati; Mathieu Vinken
Journal:  Transl Res       Date:  2015-05-16       Impact factor: 7.012

7.  Chronic prenatal hypoxia impairs cochlear development, a mechanism involving connexin26 expression and promoter methylation.

Authors:  Jingcang Lin; Huang Huang; Guorong Lv; Xiangyang Xu; Wendong Lin; Xianyan Xu; Jing Cheng; Ming Zheng
Journal:  Int J Mol Med       Date:  2017-12-01       Impact factor: 4.101

Review 8.  Choline, Other Methyl-Donors and Epigenetics.

Authors:  Steven Zeisel
Journal:  Nutrients       Date:  2017-04-29       Impact factor: 5.717

Review 9.  Regulation of connexin signaling by the epigenetic machinery.

Authors:  Mathieu Vinken
Journal:  Biochim Biophys Acta       Date:  2015-11-10

Review 10.  Connexins and pannexins in liver damage.

Authors:  Sara Crespo Yanguas; Joost Willebrords; Michaël Maes; Tereza Cristina da Silva; Isabel Veloso Alves Pereira; Bruno Cogliati; Maria Lucia Zaidan Dagli; Mathieu Vinken
Journal:  EXCLI J       Date:  2016-02-25       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.